| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Albert G. White III CEO | B3 Exchange | - ISIN |
| BR Country | 15,000 Employees | - Last Dividend | 21 Feb 2024 Last Split | 30 Dec 1983 IPO Date |
The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global corporation dedicated to fulfilling the needs of contact lens wearers and supporting women's health care through its two primary divisions: CooperVision and CooperSurgical. CooperVision specializes in the development, manufacture, and market of a wide range of contact lenses to correct various visual impairments including nearsightedness, farsightedness, astigmatism, and presbyopia across regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical focuses on delivering comprehensive solutions in family and women's healthcare by offering an extensive range of products and services that cover fertility, contraception, surgical procedures, and cryostorage for cord blood and tissue, catering to health care professionals and patients globally. The company's relentless commitment to quality, innovation, and accessibility has enabled it to establish a dominant presence in the eye care and women's health markets worldwide.
Delivers an extensive portfolio of spherical, toric, and multifocal lenses designed to address various vision challenges such as nearsightedness, farsightedness, astigmatism, and presbyopia. Among its innovative products, it offers silicone hydrogel lenses that combine comfort with oxygen permeability, enhancing the wearing experience for users.
Focused on advancing family and women's health, CooperSurgical offers a broad range of products including but not limited to fertility solutions, medical devices for surgical procedures, and non-surgical office-based interventions. Key products include Paragard—a non-hormonal IUD, fertility consumables and equipment, endosee endometrial imaging systems, Mara Water Ablation System for the treatment of heavy menstrual bleeding, and various fertility-assisting technologies like donor gamete services and genomic services involving genetic testing.
Through CooperSurgical, the company also provides cryopreservation services for cord blood and cord tissue. This service offers families the opportunity to store stem cells that could be used in future medical treatments, highlighting Cooper's commitment to supporting health throughout all stages of life.
These include a range of products designed for the diagnosis and treatment of various gynecological conditions, such as the Endosee handheld hysteroscopy system which allows for direct visualization of the endometrial cavity at the point-of-care without the need for anesthesia.
A specialized device used in cesarean sections to assist with the safe delivery of the baby, exemplifying Cooper's innovation in enhancing clinical outcomes for mothers and their newborns.